Asosiy kontentga oʻtish
Maqola

2-TOIFA QANDLI DIABET BILAN OG'RIGAN BEMORLARDA IKKI YO'LLI TRANZIT BILAN SLEEVE GASTREKTOMIYA OPERATSIYASINING GLYUKEMIK NAZORATGA TA'SIRI

2026uz
ABI

Annotatsiya

Relevance. Obesity-associated type 2 diabetes mellitus (T2DM) remains a major global health problem. Conventional medical therapy often fails to achieve sustained glycemic control. Therefore, metabolic surgery, particularly sleeve gastrectomy with bipartition (SG-B), has emerged as a promising approach for improving glucose metabolism. Purpose. To evaluate the impact of sleeve gastrectomy with bipartition on glycemic control in patients with type 2 diabetes mellitus. Materials and methods. The study included patients with obesity and T2DM who underwent SG-B. Glycemic parameters, including fasting plasma glucose and HbA1c levels, were assessed preoperatively and at 3, 6, and 12 months postoperatively. Statistical analysis was performed to evaluate changes over time. Results. A significant improvement in glycemic control was observed after surgery. Both fasting glucose and HbA1c levels demonstrated a statistically significant decrease. Additionally, a reduction or complete discontinuation of antidiabetic medications was noted in a substantial proportion of patients. Conclusion. Sleeve gastrectomy with bipartition is an effective metabolic surgical procedure for improving glycemic control in patients with type 2 diabetes mellitus. This technique contributes to better diabetes management and reduces pharmacological dependence.

Identifikatorlar

Iqtiboslar va manbalar